MiniMed Group, Inc. (MMED)

MiniMed Group Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
Net Income	-198	-107	-92
Depreciation & Amortization	143	129	115
Stock-Based Compensation	41	38	35
Other Adjustments	32	54	28
Change in Receivables	-66	-105	-70
Changes in Inventories	-19	5	-28
Changes in Accounts Payable	191	-4	14
Changes in Other Operating Activities	16	30	-6
Operating Cash Flow	140	41	-6
Operating Cash Flow Growth	241.46%	-	-
Capital Expenditures	-193	-148	-167
Purchases of Investments	-	-5	-13
Proceeds from Sale of Investments	-	11	-
Other Investing Activities	-	-14	-
Investing Cash Flow	-193	-157	-180
Other Financing Activities	10	112	185
Financing Cash Flow	10	112	185
Net Cash Flow	-43	-4	-1
Free Cash Flow	-53	-107	-173
FCF Margin	-1.95%	-4.33%	-7.71%
Free Cash Flow Per Share	-0.21	-	-
Levered Free Cash Flow	-75	-100	-168
Unlevered Free Cash Flow	-59.65	-94.46	-155.53

Updated Apr 25, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q